文献速递心脏核医学

基于J-ACCESS风险模型与心肌灌注显像的风险分层:慢性肾脏病患者的风险与结局

Risk stratification based on J-ACCESS risk models with myocardial perfusion imaging: Risk versus outcomes of patients with chronic kidney disease.
PubMed 文献 · J Nucl Cardiol · 2018-06-12

本研究在多中心J-ACCESS预后研究基础上,于526例慢性肾脏病(CKD)患者3年队列中验证三种主要心脏事件风险模型的准确性,主要事件发生率为11.2%。三种模型对eGFR≥15 mL/min/1.73 m²患者均能良好分层(模型2三组实际事件率3.1%、9.9%、15.9%,P=.0087),但eGFR<15 mL/min/1.73 m²患者各风险组实际事件率均同样高。

要点

  • 三种J-ACCESS风险模型对eGFR≥15 mL/min/1.73 m²的CKD患者可进行风险分层。
  • 模型2分层后低、中、高风险组实际事件率分别为3.1%、9.9%、15.9%(P=.0087)。
  • eGFR<15 mL/min/1.73 m²患者各风险组实际事件率均同样高,无论估计风险值如何均可能高危。

核心结论

  • J-ACCESS风险模型可对eGFR≥15 mL/min/1.73 m²的CKD患者进行分层,但eGFR<15 mL/min/1.73 m²患者无论估计风险值如何均可能处于高危。

研究设计与样本

  • 在多中心J-ACCESS预后研究基础上创建三种多变量主要心脏事件风险模型,并在CKD患者3年队列(n=526,主要事件11.2%)中验证。

主要发现

  • 模型1含年龄、负荷总评分、左心室射血分数和糖尿病四个变量;模型2含五个变量包括估算肾小球滤过率(eGFR,连续变量);模型3含分类eGFR。
  • 按低(<3%/3年)、中(3%至9%/3年)、高(>9%/3年)风险组生存分析显示三种模型均分层良好,eGFR≥15 mL/min/1.73 m²患者三组实际事件率分别为3.1%、9.9%、15.9%(模型2,P=.0087)。
  • eGFR<15 mL/min/1.73 m²患者各风险组实际事件率均同样高。

关键数值与推荐

  • 风险分层界值:低风险<3%/3年,中等风险3%至9%/3年,高风险>9%/3年。
  • 模型2在eGFR≥15 mL/min/1.73 m²患者中三组实际事件率3.1%、9.9%、15.9%(P=.0087)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aimed to validate the accuracy of major-event risk models created in the multicenter J-ACCESS prognostic study in a new cohort of patients with chronic kidney disease (CKD). METHODS AND RESULTS: Three multivariable J-ACCESS risk models were created to predict major cardiac events (cardiac death, non-fatal acute coronary syndrome, and severe heart failure requiring hospitalization): Model 1, four variables of age, summed stress score, left ventricular ejection fraction and diabetes; Model 2 with five variables including estimated glomerular filtration rate (eGFR, continuous); and Model 3 with categorical eGFR. The validation data used three-year (3y) cohort of patients with CKD (n = 526, major events 11.2%). Survival analysis of low (< 3%/3y), intermediate (3% to 9%/3y), and high (> 9%/3y)-risk groups showed good stratification by all three models (actual event rates: 3.1%, 9.9%, and 15.9% in the three groups with eGFR ≥ 15 mL/min/1.73 m2, P = .0087 (Model 2). However, actual event rates were equally high across all risk groups of patients with eGFR < 15 mL/min/1.73 m2. CONCLUSION: The J-ACCESS risk models can stratify patients with CKD and eGFR ≥ 15 mL/min/1.73 m2, but patients with eGFR < 15 mL/min/1.73 m2 are potentially at high risk regardless of estimated risk values.

来源:J Nucl Cardiol,查看原文。版权归原作者所有。

引用

  1. Nakajima K, Nakamura S, Hase H, et al. Risk stratification based on J-ACCESS risk models with myocardial perfusion imaging: Risk versus outcomes of patients with chronic kidney disease. J Nucl Cardiol. 2018. PMID: 29948890. doi:10.1007/s12350-018-1330-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。